Sense Neuro Diagnostics

Country:
USA
Founding year:
2017

Sense Neuro Diagnostics is a neurotechnology company developing a non-invasive diagnostic system focused on objective assessment of concussion and mild traumatic brain injury. The company aims to address limitations of symptom-based and subjective neurological evaluation by providing quantitative brain function measurements.

Its platform uses advanced analysis of brain signals to generate rapid, standardized outputs that support clinical decision-making. The system is designed to be quick to deploy, repeatable, and suitable for use outside of specialized neuroimaging facilities, enabling assessment at the point of care.

Sense Neuro Diagnostics’ technology is positioned for use in clinical, sports, and emergency settings where fast and objective brain injury assessment is critical. The company positions its solution as a diagnostic support tool that complements existing neurological evaluation pathways rather than a therapeutic or neuromodulation system.

Tools and Infrastructure
Diagnostics
Decision Support

Neurofounders Insights

Modality:
Others
Form Factor:
Headset/cap
Interface Depth:
Non-invasive
Indication:
Stroke
Target user:
Clinicians
Regulatory stage:
Investigational

Series B

Sense Neuro Diagnostics targets objective concussion and brain-injury assessment through non-invasive signal analysis, sitting in the same broad problem area as BrainScope and Oculogica. Its key challenge is differentiating sufficiently against more established players with stronger regulatory positions.

Related companies

Articles featuring

Sense Neuro Diagnostics

No articles yet!

Press releases

No press releases published yet.